Need help finding what you are looking for?
Contact Us
PUBLISHER: Polaris Market Research | PRODUCT CODE: 1449358
PUBLISHER: Polaris Market Research | PRODUCT CODE: 1449358
Cancer Contrast Media Market Share, Size, Trends, Industry Analysis Report, By Product (Microbubble, Gadolinium-Based, Iodinated, and Barium-Based); By Modality; By End User; By Region; Segment Forecast, 2024 - 2032
PUBLISHED:
PAGES: 119 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
The global cancer contrast media market size is expected to reach USD 1,468.79 million by 2032, according to a new study by Polaris Market Research. The report "Cancer Contrast Media Market Share, Size, Trends, Industry Analysis Report, By Product (Microbubble, Gadolinium-Based, Iodinated, and Barium-Based); By Modality; By End User; By Region; Segment Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.
The growing use of contrast media in various imaging techniques, such as MRI (Magnetic Resonance Imaging) and CT (Computed Tomography) scans, for providing accurate and clear images of affected areas is driving the market's growth. Additionally, growing research & development activities focused on improving the efficacy, safety, and specificity of contrast agents are further propelling the market's growth.
For instance, in September 2023, Philips incorporated a new super-resolution contrast-enhanced ultrasound application in their EPIQ Elite ultrasound system. The new solution enables 3 times better spatial resolution compared to previous models and could also improve diagnostic accuracy.
Furthermore, the rapid shift towards personalized medicine and targeted therapies across the globe creates new opportunities for the development of new contrast agents that can be easily tailored to specific cancer types and help in providing more accurate and effective diagnostic solutions for each patient. Also, molecular imaging is becoming increasingly popular and used in several diseases worldwide, with a particular focus on cancer care.
The potential of nanoparticles has grown drastically for the improvement of cancer diagnostics, therapeutics, and treatment management, as nanoparticles are serving as labels or even labeled carriers for better monitoring of drug delivery as well as serving as imaging agents for improved imaging contrast. Such qualities of nanoparticles offer lucrative opportunities for imaging agents in order to address the current limitations in oncologic imaging.
With the growing focus on key companies towards developing innovative cancer screening and clinical development programs that lead to early diagnosis with greater efficacy and safety, there is an increased demand for contrast media. For instance, in June 2023, Bayer announced that they had started the phase III clinical trial called QUANTI. This program mainly aims to evaluate the safety & efficacy of gadoquatrane, a next-generation contrast agent.
Cancer Contrast Media Market Report Highlights
The iodinated segment accounted for a noteworthy share on account of its significant use in CT scans and X-rays to improve imaging procedures
X-ray/compound tomography segment captured the largest share, which is attributed to its growing demand in contrast media for highlighting the anatomical features
The hospitals & clinics segment led the industry market, owing to improvements in hospital infrastructure and the availability of advanced diagnostic tools in such modalities
North America dominated the global market, that is due to the region's growing aging population and easier access to innovative cancer diagnostic tools
The key market players include Bracco Imaging, Bayer, Daiichi Sankyo, Hengrui Medicine, GE Healthcare, Subhra Pharma, and Lantheus Holdings
Polaris Market Research has segmented the cancer contrast media market report based on product, modality, end user, and region:
Cancer Contrast Media, Product Outlook (Revenue - USD Million, 2023 - 2032)
- Microbubble
- Gadolinium-Based
- Iodinated
- Barium-Based
Cancer Contrast Media, Modality Outlook (Revenue - USD Million, 2023 - 2032)
- Ultrasound
- Magnetic Resonance Imaging
- X-Ray/Computed Tomography
Cancer Contrast Media, End User Outlook (Revenue - USD Million, 2023 - 2032)
- Hospitals & Clinics
- Diagnostic Imaging Centers
- Research Institutes
- Others
Cancer Contrast Media, Regional Outlook (Revenue - USD Million, 2023 - 2032)
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Netherlands
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Indonesia
- Australia
- Malaysia
- Rest of Asia Pacific
- Latin America
- Argentina
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- UAE
- Saudi Arabia
- Israel
- South Africa
- Rest of Middle East & Africa
Product Code: PM4563
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
- 2.1. Market Highlights
3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Global Cancer Contrast Media Market Insights
- 4.1. Cancer Contrast Media Market - End User Snapshot
- 4.2. Cancer Contrast Media Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Rising population and prevalence of cancer to foster market growth
- 4.2.1.2. Advancements in diagnostic technologies driving market's growth
- 4.2.2. Restraints and Challenges
- 4.2.2.1. Side effects of contrast agents and lack of awareness restraining the market growth
- 4.2.1. Drivers and Opportunities
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Cancer Contrast Media Market End User Trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
5. Global Cancer Contrast Media Market, by Product
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Cancer Contrast Media Market, by Product, 2019-2032 (USD Billion)
- 5.3. Microbubble
- 5.3.1. Global Cancer Contrast Media Market, by Microbubble, by Region, 2019-2032 (USD Billion)
- 5.4. Gadolinium-Based
- 5.4.1. Global Cancer Contrast Media Market, by Gadolinium-Based, by Region, 2019-2032 (USD Billion)
- 5.5. Iodinated
- 5.5.1. Global Cancer Contrast Media Market, by Iodinated, by Region, 2019-2032 (USD Billion)
- 5.6. Barium-Based
- 5.6.1. Global Cancer Contrast Media Market, by Barium-Based, by Region, 2019-2032 (USD Billion)
6. Global Cancer Contrast Media Market, by Modality
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Cancer Contrast Media Market, by Modality, 2019-2032 (USD Billion)
- 6.3. Barium-Based
- 6.3.1. Global Cancer Contrast Media Market, by Barium-Based, by Region, 2019-2032 (USD Billion)
- 6.4. Magnetic Resonance Imaging
- 6.4.1. Global Cancer Contrast Media Market, by Magnetic Resonance Imaging, by Region, 2019-2032 (USD Billion)
- 6.5. X-Ray/Computed Tomography
- 6.5.1. Global Cancer Contrast Media Market, by X-Ray/Computed Tomography, by Region, 2019-2032 (USD Billion)
7. Global Cancer Contrast Media Market, by End User
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global Cancer Contrast Media Market, by End User, 2019-2032 (USD Billion)
- 7.3. Hospitals & Clinics
- 7.3.1. Global Cancer Contrast Media Market, by Hospitals & Clinics, By Region, 2019-2032 (USD Billion)
- 7.4. Diagnostic Imaging Centers
- 7.4.1. Global Cancer Contrast Media Market, by Diagnostic Imaging Centers, By Region, 2019-2032 (USD Billion)
- 7.5. Research Institutes
- 7.5.1. Global Cancer Contrast Media Market, by Research Institutes, By Region, 2019-2032 (USD Billion)
- 7.6. Others
- 7.6.1. Global Cancer Contrast Media Market, by Others, By Region, 2019-2032 (USD Billion)
8. Global Cancer Contrast Media Market, by Geography
- 8.1. Key findings
- 8.2. Introduction
- 8.2.1. Cancer Contrast Media Market Assessment, By Geography, 2019-2032 (USD Billion)
- 8.3. Cancer Contrast Media Market - North America
- 8.3.1. North America: Cancer Contrast Media Market, by Product, 2019-2032 (USD Billion)
- 8.3.2. North America: Cancer Contrast Media Market, by End User, 2019-2032 (USD Billion)
- 8.3.3. North America: Cancer Contrast Media Market, by Modality, 2019-2032 (USD Billion)
- 8.3.4. Cancer Contrast Media Market - U.S.
- 8.3.4.1. U.S.: Cancer Contrast Media Market, by Product, 2019-2032 (USD Billion)
- 8.3.4.2. U.S.: Cancer Contrast Media Market, by End User, 2019-2032 (USD Billion)
- 8.3.4.3. U.S.: Cancer Contrast Media Market, by Modality, 2019-2032 (USD Billion)
- 8.3.5. Cancer Contrast Media Market - Canada
- 8.3.5.1. Canada: Cancer Contrast Media Market, by Product, 2019-2032 (USD Billion)
- 8.3.5.2. Canada.: Cancer Contrast Media Market, by End User, 2019-2032 (USD Billion)
- 8.3.5.3. Canada: Cancer Contrast Media Market, by Modality, 2019-2032 (USD Billion)
- 8.4. Cancer Contrast Media Market - Europe
- 8.4.1. Europe: Cancer Contrast Media Market, by Product, 2019-2032 (USD Billion)
- 8.4.2. Europe.: Cancer Contrast Media Market, by End User, 2019-2032 (USD Billion)
- 8.4.3. Europe: Cancer Contrast Media Market, by Modality, 2019-2032 (USD Billion)
- 8.4.4. Cancer Contrast Media Market - UK
- 8.4.4.1. UK: Cancer Contrast Media Market, by Product, 2019-2032 (USD Billion)
- 8.4.4.2. UK.: Cancer Contrast Media Market, by End User, 2019-2032 (USD Billion)
- 8.4.4.3. UK: Cancer Contrast Media Market, by Modality, 2019-2032 (USD Billion)
- 8.4.5. Cancer Contrast Media Market - France
- 8.4.5.1. France: Cancer Contrast Media Market, by Product, 2019-2032 (USD Billion)
- 8.4.5.2. France.: Cancer Contrast Media Market, by End User, 2019-2032 (USD Billion)
- 8.4.5.3. France: Cancer Contrast Media Market, by Modality, 2019-2032 (USD Billion)
- 8.4.6. Cancer Contrast Media Market - Germany
- 8.4.6.1. Germany: Cancer Contrast Media Market, by Product, 2019-2032 (USD Billion)
- 8.4.6.2. Germany.: Cancer Contrast Media Market, by End User, 2019-2032 (USD Billion)
- 8.4.6.3. Germany: Cancer Contrast Media Market, by Modality, 2019-2032 (USD Billion)
- 8.4.7. Cancer Contrast Media Market - Italy
- 8.4.7.1. Italy: Cancer Contrast Media Market, by Product, 2019-2032 (USD Billion)
- 8.4.7.2. Italy.: Cancer Contrast Media Market, by End User, 2019-2032 (USD Billion)
- 8.4.7.3. Italy: Cancer Contrast Media Market, by Modality, 2019-2032 (USD Billion)
- 8.4.8. Cancer Contrast Media Market - Spain
- 8.4.8.1. Spain: Cancer Contrast Media Market, by Product, 2019-2032 (USD Billion)
- 8.4.8.2. Spain.: Cancer Contrast Media Market, by End User, 2019-2032 (USD Billion)
- 8.4.8.3. Spain: Cancer Contrast Media Market, by Modality, 2019-2032 (USD Billion)
- 8.4.9. Cancer Contrast Media Market - Netherlands
- 8.4.9.1. Netherlands: Cancer Contrast Media Market, by Product, 2019-2032 (USD Billion)
- 8.4.9.2. Netherlands.: Cancer Contrast Media Market, by End User, 2019-2032 (USD Billion)
- 8.4.9.3. Netherlands: Cancer Contrast Media Market, by Modality, 2019-2032 (USD Billion)
- 8.4.10. Cancer Contrast Media Market - Russia
- 8.4.10.1. Russia: Cancer Contrast Media Market, by Product, 2019-2032 (USD Billion)
- 8.4.10.2. Russia.: Cancer Contrast Media Market, by End User, 2019-2032 (USD Billion)
- 8.4.10.3. Russia: Cancer Contrast Media Market, by Modality, 2019-2032 (USD Billion)
- 8.5. Cancer Contrast Media Market - Asia Pacific
- 8.5.1. Asia Pacific: Cancer Contrast Media Market, by Product, 2019-2032 (USD Billion)
- 8.5.2. Asia Pacific.: Cancer Contrast Media Market, by End User, 2019-2032 (USD Billion)
- 8.5.3. Asia Pacific: Cancer Contrast Media Market, by Modality, 2019-2032 (USD Billion)
- 8.5.4. Cancer Contrast Media Market - China
- 8.5.4.1. China: Cancer Contrast Media Market, by Product, 2019-2032 (USD Billion)
- 8.5.4.2. China.: Cancer Contrast Media Market, by End User, 2019-2032 (USD Billion)
- 8.5.4.3. China: Cancer Contrast Media Market, by Modality, 2019-2032 (USD Billion)
- 8.5.5. Cancer Contrast Media Market - India
- 8.5.5.1. India: Cancer Contrast Media Market, by Product, 2019-2032 (USD Billion)
- 8.5.5.2. India.: Cancer Contrast Media Market, by End User, 2019-2032 (USD Billion)
- 8.5.5.3. India: Cancer Contrast Media Market, by Modality, 2019-2032 (USD Billion)
- 8.5.6. Cancer Contrast Media Market - Malaysia
- 8.5.6.1. Malaysia: Cancer Contrast Media Market, by Product, 2019-2032 (USD Billion)
- 8.5.6.2. Malaysia.: Cancer Contrast Media Market, by End User, 2019-2032 (USD Billion)
- 8.5.6.3. Malaysia: Cancer Contrast Media Market, by Modality, 2019-2032 (USD Billion)
- 8.5.7. Cancer Contrast Media Market - Japan
- 8.5.7.1. Japan: Cancer Contrast Media Market, by Product, 2019-2032 (USD Billion)
- 8.5.7.2. Japan.: Cancer Contrast Media Market, by End User, 2019-2032 (USD Billion)
- 8.5.7.3. Japan: Cancer Contrast Media Market, by Modality, 2019-2032 (USD Billion)
- 8.5.8. Cancer Contrast Media Market - Indonesia
- 8.5.8.1. Indonesia: Cancer Contrast Media Market, by Product, 2019-2032 (USD Billion)
- 8.5.8.2. Indonesia.: Cancer Contrast Media Market, by End User, 2019-2032 (USD Billion)
- 8.5.8.3. Indonesia: Cancer Contrast Media Market, by Modality, 2019-2032 (USD Billion)
- 8.5.9. Cancer Contrast Media Market - South Korea
- 8.5.9.1. South Korea: Cancer Contrast Media Market, by Product, 2019-2032 (USD Billion)
- 8.5.9.2. South Korea.: Cancer Contrast Media Market, by End User, 2019-2032 (USD Billion)
- 8.5.9.3. South Korea: Cancer Contrast Media Market, by Modality, 2019-2032 (USD Billion)
- 8.6. Cancer Contrast Media Market - Middle East & Africa
- 8.6.1. Middle East & Africa: Cancer Contrast Media Market, by Product, 2019-2032 (USD Billion)
- 8.6.2. Middle East & Africa.: Cancer Contrast Media Market, by End User, 2019-2032 (USD Billion)
- 8.6.3. Middle East & Africa: Cancer Contrast Media Market, by Modality, 2019-2032 (USD Billion)
- 8.6.4. Cancer Contrast Media Market - Saudi Arabia
- 8.6.4.1. Saudi Arabia: Cancer Contrast Media Market, by Product, 2019-2032 (USD Billion)
- 8.6.4.2. Saudi Arabia.: Cancer Contrast Media Market, by End User, 2019-2032 (USD Billion)
- 8.6.4.3. Saudi Arabia: Cancer Contrast Media Market, by Modality, 2019-2032 (USD Billion)
- 8.6.5. Cancer Contrast Media Market - UAE
- 8.6.5.1. UAE: Cancer Contrast Media Market, by Product, 2019-2032 (USD Billion)
- 8.6.5.2. UAE.: Cancer Contrast Media Market, by End User, 2019-2032 (USD Billion)
- 8.6.5.3. UAE: Cancer Contrast Media Market, by Modality, 2019-2032 (USD Billion)
- 8.6.6. Cancer Contrast Media Market - Israel
- 8.6.6.1. Israel: Cancer Contrast Media Market, by Product, 2019-2032 (USD Billion)
- 8.6.6.2. Israel.: Cancer Contrast Media Market, by End User, 2019-2032 (USD Billion)
- 8.6.6.3. Israel: Cancer Contrast Media Market, by Modality, 2019-2032 (USD Billion)
- 8.6.7. Cancer Contrast Media Market - South Africa
- 8.6.7.1. South Africa: Cancer Contrast Media Market, by Product, 2019-2032 (USD Billion)
- 8.6.7.2. South Africa.: Cancer Contrast Media Market, by End User, 2019-2032 (USD Billion)
- 8.6.7.3. South Africa: Cancer Contrast Media Market, by Modality, 2019-2032 (USD Billion)
- 8.7. Cancer Contrast Media Market - Latin America
- 8.7.1. Latin America: Cancer Contrast Media Market, by Product, 2019-2032 (USD Billion)
- 8.7.2. Latin America.: Cancer Contrast Media Market, by End User, 2019-2032 (USD Billion)
- 8.7.3. Latin America: Cancer Contrast Media Market, by Modality, 2019-2032 (USD Billion)
- 8.7.4. Cancer Contrast Media Market - Mexico
- 8.7.4.1. Mexico: Cancer Contrast Media Market, by Product, 2019-2032 (USD Billion)
- 8.7.4.2. Mexico.: Cancer Contrast Media Market, by End User, 2019-2032 (USD Billion)
- 8.7.4.3. Mexico: Cancer Contrast Media Market, by Modality, 2019-2032 (USD Billion)
- 8.7.5. Cancer Contrast Media Market - Brazil
- 8.7.5.1. Brazil: Cancer Contrast Media Market, by Product, 2019-2032 (USD Billion)
- 8.7.5.2. Brazil.: Cancer Contrast Media Market, by End User, 2019-2032 (USD Billion)
- 8.7.5.3. Brazil: Cancer Contrast Media Market, by Modality, 2019-2032 (USD Billion)
- 8.7.6. Cancer Contrast Media Market - Argentina
- 8.7.6.1. Argentina: Cancer Contrast Media Market, by Product, 2019-2032 (USD Billion)
- 8.7.6.2. Argentina.: Cancer Contrast Media Market, by End User, 2019-2032 (USD Billion)
- 8.7.6.3. Argentina: Cancer Contrast Media Market, by Modality, 2019-2032 (USD Billion)
9. Competitive Landscape
- 9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
- 9.2. Partnerships/Collaborations/Agreements/Exhibitions
10. Company Profiles
- 10.1. Bayer AG (Germany)
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
- 10.2. Bracco Imaging SPA (Italy)
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
- 10.3. Daiichi Sankyo Company Limited (Japan)
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
- 10.4. Gadovist Laboratories (Canada)
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
- 10.5. GE Healthcare (US)
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
- 10.6. Guerbet (France)
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
- 10.7. Hengrui Medicine Co. Ltd. (China)
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
- 10.8. J.B. Chemicals & Pharmaceutical Ltd. (India)
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
- 10.9. Lantheus Holdings Inc. (US)
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
- 10.10. NanoScan Imaging (US)
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development
- 10.11. Subhra Pharma Pvt. Ltd. (India)
- 10.11.1. Company Overview
- 10.11.2. Financial Performance
- 10.11.3. Product Benchmarking
- 10.11.4. Recent Development
- 10.12. Taejoon Pharm Co. Ltd. (South Korea)
- 10.12.1. Company Overview
- 10.12.2. Financial Performance
- 10.12.3. Product Benchmarking
- 10.12.4. Recent Development
Product Code: PM4563
List of Tables
- Table 1 Global Cancer Contrast Media Market, by Product, 2019-2032 (USD Billion)
- Table 2 Global Cancer Contrast Media Market, by Modality, 2019-2032 (USD Billion)
- Table 3 Global Cancer Contrast Media Market, by End User, 2019-2032 (USD Billion)
- Table 4 Cancer Contrast Media Market Assessment, By Geography, 2019-2032 (USD Billion)
- Table 5 North America: Cancer Contrast Media Market, by Product, 2019-2032 (USD Billion)
- Table 6 North America: Cancer Contrast Media Market, by Modality, 2019-2032 (USD Billion)
- Table 7 North America: Cancer Contrast Media Market, by End User, 2019-2032 (USD Billion)
- Table 8 U.S.: Cancer Contrast Media Market, by Product, 2019-2032 (USD Billion)
- Table 9 U.S.: Cancer Contrast Media Market, by Modality, 2019-2032 (USD Billion)
- Table 10 U.S.: Cancer Contrast Media Market, by End User, 2019-2032 (USD Billion)
- Table 11 Canada: Cancer Contrast Media Market, by Product, 2019-2032 (USD Billion)
- Table 12 Canada: Cancer Contrast Media Market, by Modality, 2019-2032 (USD Billion)
- Table 13 Canada: Cancer Contrast Media Market, by End User, 2019-2032 (USD Billion)
- Table 14 Europe: Cancer Contrast Media Market, by Product, 2019-2032 (USD Billion)
- Table 15 Europe: Cancer Contrast Media Market, by Modality, 2019-2032 (USD Billion)
- Table 16 Europe: Cancer Contrast Media Market, by End User, 2019-2032 (USD Billion)
- Table 17 UK: Cancer Contrast Media Market, by Product, 2019-2032 (USD Billion)
- Table 18 UK: Cancer Contrast Media Market, by Modality, 2019-2032 (USD Billion)
- Table 19 UK: Cancer Contrast Media Market, by End User, 2019-2032 (USD Billion)
- Table 20 France: Cancer Contrast Media Market, by Product, 2019-2032 (USD Billion)
- Table 21 France: Cancer Contrast Media Market, by Modality, 2019-2032 (USD Billion)
- Table 22 France: Cancer Contrast Media Market, by End User, 2019-2032 (USD Billion)
- Table 23 Germany: Cancer Contrast Media Market, by Product, 2019-2032 (USD Billion)
- Table 24 Germany: Cancer Contrast Media Market, by Modality, 2019-2032 (USD Billion)
- Table 25 Germany: Cancer Contrast Media Market, by End User, 2019-2032 (USD Billion)
- Table 26 Italy: Cancer Contrast Media Market, by Product, 2019-2032 (USD Billion)
- Table 27 Italy: Cancer Contrast Media Market, by Modality, 2019-2032 (USD Billion)
- Table 28 Italy: Cancer Contrast Media Market, by End User, 2019-2032 (USD Billion)
- Table 29 Spain: Cancer Contrast Media Market, by Product, 2019-2032 (USD Billion)
- Table 30 Spain: Cancer Contrast Media Market, by Modality, 2019-2032 (USD Billion)
- Table 31 Spain: Cancer Contrast Media Market, by End User, 2019-2032 (USD Billion)
- Table 32 Netherlands: Cancer Contrast Media Market, by Product, 2019-2032 (USD Billion)
- Table 33 Netherlands: Cancer Contrast Media Market, by Modality, 2019-2032 (USD Billion)
- Table 34 Netherlands: Cancer Contrast Media Market, by End User, 2019-2032 (USD Billion)
- Table 35 Russia: Cancer Contrast Media Market, by Product, 2019-2032 (USD Billion)
- Table 36 Russia: Cancer Contrast Media Market, by Modality, 2019-2032 (USD Billion)
- Table 37 Russia: Cancer Contrast Media Market, by End User, 2019-2032 (USD Billion)
- Table 38 Asia Pacific: Cancer Contrast Media Market, by Product, 2019-2032 (USD Billion)
- Table 39 Asia Pacific: Cancer Contrast Media Market, by Modality, 2019-2032 (USD Billion)
- Table 40 Asia Pacific: Cancer Contrast Media Market, by End User, 2019-2032 (USD Billion)
- Table 41 China: Cancer Contrast Media Market, by Product, 2019-2032 (USD Billion)
- Table 42 China: Cancer Contrast Media Market, by Modality, 2019-2032 (USD Billion)
- Table 43 China: Cancer Contrast Media Market, by End User, 2019-2032 (USD Billion)
- Table 44 India: Cancer Contrast Media Market, by Product, 2019-2032 (USD Billion)
- Table 45 India: Cancer Contrast Media Market, by Modality, 2019-2032 (USD Billion)
- Table 46 India: Cancer Contrast Media Market, by End User, 2019-2032 (USD Billion)
- Table 47 Malaysia: Cancer Contrast Media Market, by Product, 2019-2032 (USD Billion)
- Table 48 Malaysia: Cancer Contrast Media Market, by Modality, 2019-2032 (USD Billion)
- Table 49 Malaysia: Cancer Contrast Media Market, by End User, 2019-2032 (USD Billion)
- Table 50 Japan: Cancer Contrast Media Market, by Product, 2019-2032 (USD Billion)
- Table 51 Japan: Cancer Contrast Media Market, by Modality, 2019-2032 (USD Billion)
- Table 52 Japan: Cancer Contrast Media Market, by End User, 2019-2032 (USD Billion)
- Table 53 Indonesia: Cancer Contrast Media Market, by Product, 2019-2032 (USD Billion)
- Table 54 Indonesia: Cancer Contrast Media Market, by Modality, 2019-2032 (USD Billion)
- Table 55 Indonesia: Cancer Contrast Media Market, by End User, 2019-2032 (USD Billion)
- Table 56 South Korea: Cancer Contrast Media Market, by Product, 2019-2032 (USD Billion)
- Table 57 South Korea: Cancer Contrast Media Market, by Modality, 2019-2032 (USD Billion)
- Table 58 South Korea: Cancer Contrast Media Market, by End User, 2019-2032 (USD Billion)
- Table 59 Middle East & Africa: Cancer Contrast Media Market, by Product, 2019-2032 (USD Billion)
- Table 60 Middle East & Africa: Cancer Contrast Media Market, by Modality, 2019-2032 (USD Billion)
- Table 61 Middle East & Africa: Cancer Contrast Media Market, by End User, 2019-2032 (USD Billion)
- Table 62 Saudi Arabia: Cancer Contrast Media Market, by Product, 2019-2032 (USD Billion)
- Table 63 Saudi Arabia: Cancer Contrast Media Market, by Modality, 2019-2032 (USD Billion)
- Table 64 Saudi Arabia: Cancer Contrast Media Market, by End User, 2019-2032 (USD Billion)
- Table 65 UAE: Cancer Contrast Media Market, by Product, 2019-2032 (USD Billion)
- Table 66 UAE: Cancer Contrast Media Market, by Modality, 2019-2032 (USD Billion)
- Table 67 UAE: Cancer Contrast Media Market, by End User, 2019-2032 (USD Billion)
- Table 68 Israel: Cancer Contrast Media Market, by Product, 2019-2032 (USD Billion)
- Table 69 Israel: Cancer Contrast Media Market, by Modality, 2019-2032 (USD Billion)
- Table 70 Israel: Cancer Contrast Media Market, by End User, 2019-2032 (USD Billion)
- Table 71 South Africa: Cancer Contrast Media Market, by Product, 2019-2032 (USD Billion)
- Table 72 South Africa: Cancer Contrast Media Market, by Modality, 2019-2032 (USD Billion)
- Table 73 South Africa: Cancer Contrast Media Market, by End User, 2019-2032 (USD Billion)
- Table 74 Latin America: Cancer Contrast Media Market, by Product, 2019-2032 (USD Billion)
- Table 75 Latin America: Cancer Contrast Media Market, by Modality, 2019-2032 (USD Billion)
- Table 76 Latin America: Cancer Contrast Media Market, by End User, 2019-2032 (USD Billion)
- Table 77 Mexico: Cancer Contrast Media Market, by Product, 2019-2032 (USD Billion)
- Table 78 Mexico: Cancer Contrast Media Market, by Modality, 2019-2032 (USD Billion)
- Table 79 Mexico: Cancer Contrast Media Market, by End User, 2019-2032 (USD Billion)
- Table 80 Brazil: Cancer Contrast Media Market, by Product, 2019-2032 (USD Billion)
- Table 81 Brazil: Cancer Contrast Media Market, by Modality, 2019-2032 (USD Billion)
- Table 82 Brazil: Cancer Contrast Media Market, by End User, 2019-2032 (USD Billion)
- Table 83 Argentina: Cancer Contrast Media Market, by Product, 2019-2032 (USD Billion)
- Table 84 Argentina: Cancer Contrast Media Market, by Modality, 2019-2032 (USD Billion)
- Table 85 Argentina: Cancer Contrast Media Market, by End User, 2019-2032 (USD Billion)
List of Figures
- Figure 1. Global Cancer Contrast Media Market, 2019-2032 (USD Billion)
- Figure 2. Integrated Ecosystem
- Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
- Figure 4. Market by Geography
- Figure 5. Porter's Five Forces
- Figure 6. Market by Modality
- Figure 7. Global Cancer Contrast Media Market, by Modality, 2022 & 2032 (USD Billion)
- Figure 8. Market by Product
- Figure 9. Global Cancer Contrast Media Market, by Product, 2022 & 2032 (USD Billion)
- Figure 10. Market by End User
- Figure 11. Global Cancer Contrast Media Market, by End User, 2022 & 2032 (USD Billion)
- Figure 12. Cancer Contrast Media Market Assessment, By Geography, 2019-2032 (USD Billion)
- Figure 13. Strategic Analysis - Cancer Contrast Media Market
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.